Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03963323 · ClinicalTrials.gov registry record · Phase 1
Glucosamine and Chondroitin in Gut in Preventing People From Inflammation
A Phase 1 study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT03963323 is a Phase 1 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 9 participants.
The verdict
NCT03963323, a Phase 1 study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This trial studies glucosamine and chondroitin in preventing inflammation. Glucosamine and chondroitin often used as a dietary supplement to promote joint health may have a preventive role in inflammation and cancer. This trial may help identify the bacteria that help process them in the gut.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Glucosamine Sulfate/Chondroitin Sulfate Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-05-11 |
| Est. Completion | 2019-03-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03963323
The ClinicalTrials.gov registry entry for NCT03963323 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03963323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03963323 about?
NCT03963323 is a clinical study titled "Glucosamine and Chondroitin in Gut in Preventing People From Inflammation". This trial studies glucosamine and chondroitin in preventing inflammation. Glucosamine and chondroitin often used as a dietary supplement to promote joint health may have a preventive role in inflammation and cancer. This trial may help identify the bacteria that help process them in the gut.
What is the current status of trial NCT03963323?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2018-05-11. Estimated completion is 2019-03-31.
What interventions are being tested in trial NCT03963323?
The interventions under investigation include: Placebo (OTHER), Glucosamine Sulfate/Chondroitin Sulfate Tablet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03963323?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.